Skip to content

CorMedix CRMD Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five)

Finite-Lived Intangible Assets - Expected Amortization Expense (Year Five) at other companies

Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$12.99M
IAR
Integra LifeSciencesIART
ICU Medical logo
ICU MedicalICUI
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's finite-lived intangible assets - expected amortization expense (year five).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's finite-lived intangible assets - expected amortization expense (year five)?
CorMedix (CRMD) reported finite-lived intangible assets - expected amortization expense (year five) of $33.44K in Q4 2025.
What does finite-lived intangible assets - expected amortization expense (year five) mean?
This represents the projected non-cash expense related to the systematic write-down of finite-lived intangible assets in the fifth year following the reporting date. It provides visibility into the long-term impact of acquisition-related intangible assets on future earnings. Investors use this to forecast future profitability and assess the durability of the company's intangible asset base.